GlassScriptPhysician profile
Kunal Angra
NPI 1871988147
$1,844.31
in general payments reported to CMS, 2019-2025
19 companies · $72.93 in 2025
The $72.93 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $134 · 2021: $702 · 2022: $264 · 2023: $329 · 2024: $342 · 2025: $72.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.33 |
| Education | $166.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $460.82 | 2020-2025 | Ubrelvy, Qulipta |
| Vyne Pharmaceuticals INC. | $217.19 | 2021 | |
| Allergan, INC. | $213.40 | 2020-2022 | |
| Janssen Biotech, INC. | $189.08 | 2021-2024 | Tremfya |
| Galderma Laboratories, L.P. | $168.18 | 2020-2024 | |
| Lilly USA, LLC | $149.46 | 2021-2023 | Jardiance, Olumiant, Taltz |
| Leo Pharma INC. | $71.08 | 2021 | |
| Pfizer INC. | $69.62 | 2021-2023 | |
| Amgen INC. | $45.62 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $44.26 | 2021-2025 | Dupixent |
| Incyte Corporation | $39.51 | 2021 | |
| Sun Pharmaceutical Industries INC. | $37.02 | 2021 | |
| Dermavant Sciences, INC. | $29.92 | 2023 | Vtama |
| Arcutis Biotherapeutics, INC. | $19.82 | 2025 | Zoryve |
| Solta Medical, A Division of Bausch Health US, LLC | $19.80 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.20 | 2022 | |
| Boston Scientific Corporation | $17.05 | 2023 | Wavewriter Alpha Prime 16 |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.69 | 2020 | |
| Genentech USA, INC. | $16.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Angra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.